Colorado VSS #IFB1-CAAA-2022000010-3

Colorado Procurement and Award for Infliximab Infusion Pharmaceuticals (Remicade and Renflexis)

This procurement opportunity involves the State of Colorado's acquisition of Infliximab pharmaceutical products for infusion therapy. - Government Buyer: - State of Colorado (specific agency not named) - OEMs and Vendors: - Original Equipment Manufacturers (OEMs): - Janssen Biotech, Inc. (Remicade) - Samsung Bioepis Co., Ltd. (Renflexis) - Awarded Vendor: Honest Oak, LLC. - Products/Services Requested: - Infliximab pharmaceutical products for infusion - Acceptable brands: Remicade and Renflexis - No specific part numbers or quantities provided - Unique or Notable Requirements: - Only infusion form of Infliximab accepted - Delivery required to a specified state facility in Pueblo, CO - Electronic response submission was mandatory - Solicitation included updates to site locations and extended submission deadlines - Award was made for the full requested amount ($24,999.00) - Period of Performance: - Approximately one year - Delivery and Billing Locations: - Delivery: 1600 W. 24th St. Bldg 16, Pueblo, CO - Billing: P.O. Box 1010, Canon City, CO

Description

This solicitation is an invitation for bids for the procurement of Infliximab Pharmaceutical products, specifically Infusion Infliximab (Remicade) and (Renflexis). The delivery location is specified as 1600 W. 24TH ST. BLDG 16, Pueblo, CO, with billing to P.O. Box 1010, Canon City, CO. The contract period spans from July 1, 2021, to June 27, 2022. The awarded contract was given to Honest Oak, LLC. for $24,999.00.

View original listing